No Data
New Research From Waystar and Modern Healthcare Reveals AI's Transformative Impact on Healthcare Payments
Waystar Holding Price Target Raised to $31.00/Share From $27.00 by RBC Capital
RBC Capital Maintains Waystar Holding(WAY.US) With Buy Rating, Raises Target Price to $31
RBC Capital analyst Sean Dodge maintains $Waystar Holding(WAY.US)$ with a buy rating, and adjusts the target price from $27 to $31.According to TipRanks data, the analyst has a success rate of 42.1%
RBC Capital Remains a Buy on Waystar Holding Corp. (WAY)
Waystar Wins Stevie Awards for Company of the Year and AI Solutions in Healthcare
JP Morgan Maintains Overweight on Waystar Holding, Raises Price Target to $27